ALICIA BELL: Open Payments
NPI 1760506604 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,449 in 83 payments from 23 companies in 2025. Trend: 2023 $764 · 2024 $1,303 · 2025 $2,449
Food & beverage: $2,389Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $461 |
| UCB, Inc. | 13 | $379 |
| Amgen Inc. | 14 | $247 |
| Mallinckrodt Hospital Products Inc. | 5 | $186 |
| GlaxoSmithKline, LLC. | 2 | $145 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| Dexcom, Inc. | 1 | $91 |
Products named: Bimzelx, RINVOQ, ACTHAR, BENLYSTA, FANAPT, UBRELVY, TZIELD, COSENTYX.
Industry payments across AR — which companies pay providers there.
